Insider Ledger
Adicet Bio, Inc. (ACET) insider buying and SEC filings
Adicet Bio, Inc. · CIK 1720580
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 26
- Former names
- resTORbio, Inc.
Insider activity in the last 12 months
Bought
$1.6M
Insiders who bought
1
Sold (not marked 10b5-1)
$675K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Feb 18–20, 2026 | Purchase (code P) | Peter Kolchinsky (10% owner) bought 223,596 shares indirectly between Feb 18 and Feb 20 at about $7.17 ($1.6M), reported as a purchase (code P). Indirect holdings up 23% to 1,182,624 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Apr 13, 2026 |
| Apr 7–8, 2026 | Sale | ORBIMED ADVISORS LLC (10% owner) sold 104,658 shares indirectly between Apr 7 and Apr 8 at about $6.45 ($675K). Indirect holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners. | SEC filing Filed Apr 9, 2026 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ACET in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.